InvestorsHub Logo
Followers 16
Posts 1933
Boards Moderated 1
Alias Born 10/23/2004

Re: None

Sunday, 02/14/2021 11:23:09 AM

Sunday, February 14, 2021 11:23:09 AM

Post# of 460
And again, for today's final:

Collected from the last CEO interview

Steve basically said there was too much opportunity cost lost waiting for the MDEL application and so they partnered with Medipro, which already has MDEL, to get it quicker which means steve has big contracts waiting for MDEL i want to make a list on nasdaq again as soon as we can. Better organic. Steve says there are discussions going on with the public sector, the private sector, cruise lines mentioned again, and locations in the Caribbean and Mexico. Says that they get demand from there. Discussions with Air Canada and Westjet, as well as private airlines, were mentioned. In the USA, exceptional demand for their products, for example for rapid antigen tests, has been identified. Can you get ONLY your clinics with Rexall ALONE 100 million revenue per year if you have possibly at least 10% or about 40 Rexall clinics, which can be 12-18 months, or sooner? Mention again how their tests work if a consumer takes their test 72 hours before departure and then consumers send it to their laboratory with the special 24-hour delivery note that has already been sent. Then they would receive their results via text or email. Steve says it's a very simple process. Steve also mentioned that they are working on their tests to recognize the new variants. Active looking for laboratory acquisitions in Canada. Submitted to be DTC Eligible, which is currently happening and expects DTC eligibility to be completed by the end of this month, which will allow many more Americans to trade / invest in CBDT. The American market is 10 times larger than the Canadian. Most of the time, Canadian buyers are buying CBDT. Mentioned in the coming weeks, Empower and Medipro will be distributing test samples from KAI to large Canadian companies